AAPL289.16+7.42 (+2.63%) ▲|ABBV252.55-1.76 (-0.69%) ▼|ABT91.62-1.09 (-1.18%) ▼|ACN123.89-0.85 (-0.68%) ▼|ADBE202.40-4.04 (-1.95%) ▼|AMAT730.21+35.57 (+5.12%) ▲|AMD572.95+33.46 (+6.20%) ▲|AMGN359.32-1.23 (-0.34%) ▼|AMT164.00-4.67 (-2.77%) ▼|AMZN239.47-0.67 (-0.28%) ▼|AVGO375.32+2.87 (+0.77%) ▲|AXP337.93-2.95 (-0.87%) ▼|BA216.73+2.04 (+0.95%) ▲|BAC57.02-0.87 (-1.49%) ▼|BKNG179.97-2.44 (-1.34%) ▼|BLK961.93+11.76 (+1.24%) ▲|BMY57.76-0.81 (-1.37%) ▼|BNY144.96+1.16 (+0.81%) ▲|BRK-B496.56+0.56 (+0.11%) ▲|C140.00-2.49 (-1.75%) ▼|CAT1,063.07+29.88 (+2.89%) ▲|CL91.95-0.46 (-0.49%) ▼|CMCSA24.54+0.32 (+1.30%) ▲|COF200.47-1.81 (-0.89%) ▼|COP104.36+0.16 (+0.15%) ▲|COST936.72-9.96 (-1.05%) ▼|CRM154.85-3.08 (-1.95%) ▼|CSCO118.13+0.43 (+0.36%) ▲|CVS103.39-0.20 (-0.19%) ▼|CVX167.77-0.70 (-0.42%) ▼|DE627.71+2.70 (+0.43%) ▲|DHR190.17-2.61 (-1.35%) ▼|DIS96.82-1.07 (-1.09%) ▼|DUK127.75-0.58 (-0.45%) ▼|EMR143.17+0.35 (+0.25%) ▲|FDX310.30-15.10 (-4.64%) ▼|GD352.36+4.29 (+1.23%) ▲|GE372.14-1.57 (-0.42%) ▼|GEV1,136.11+33.60 (+3.05%) ▲|GILD125.94-0.40 (-0.31%) ▼|GM76.24-1.10 (-1.42%) ▼|GOOG353.23+1.95 (+0.56%) ▲|GOOGL356.25+2.60 (+0.74%) ▲|GS1,012.12-8.09 (-0.79%) ▼|HD351.68+0.87 (+0.25%) ▲|HON223.56-4.24 (-1.86%) ▼|IBM277.94-0.06 (-0.02%) ▼|INTC139.67+7.95 (+6.04%) ▲|INTU261.85-4.55 (-1.71%) ▼|ISRG402.03-3.94 (-0.97%) ▼|JNJ255.29-3.23 (-1.25%) ▼|JPM327.51-1.88 (-0.57%) ▼|KO82.02-0.63 (-0.76%) ▼|LIN519.52+8.46 (+1.65%) ▲|LLY1,209.02-20.91 (-1.70%) ▼|LMT505.63+3.56 (+0.71%) ▲|LOW219.21-0.44 (-0.20%) ▼|LRCX426.47+15.56 (+3.79%) ▲|MA511.55+1.91 (+0.37%) ▲|MCD269.20+2.02 (+0.76%) ▲|MDLZ58.98-1.17 (-1.95%) ▼|MDT79.32-1.62 (-2.00%) ▼|META556.23-6.37 (-1.13%) ▼|MMM162.36-0.08 (-0.05%) ▼|MO72.57-1.48 (-2.00%) ▼|MRK128.35-1.03 (-0.80%) ▼|MS209.12-2.60 (-1.23%) ▼|MSFT370.29+1.72 (+0.47%) ▲|MU1,143.41-1.88 (-0.16%) ▼|NEE88.15-0.51 (-0.58%) ▼|NFLX72.68-1.11 (-1.50%) ▼|NKE41.04-0.45 (-1.07%) ▼|NOW97.61-2.37 (-2.37%) ▼|NVDA198.38+3.41 (+1.75%) ▲|ORCL145.41-2.36 (-1.59%) ▼|PEP136.34-2.34 (-1.69%) ▼|PFE24.08-0.29 (-1.19%) ▼|PG145.79-2.67 (-1.80%) ▼|PLTR116.87+1.17 (+1.01%) ▲|PM179.75-3.13 (-1.71%) ▼|QCOM186.61-2.11 (-1.12%) ▼|RTX188.55+1.22 (+0.65%) ▲|SBUX102.88-1.18 (-1.13%) ▼|SCHW92.47+1.92 (+2.12%) ▲|SO96.40-0.36 (-0.37%) ▼|SPG224.92-2.65 (-1.16%) ▼|T20.90-0.93 (-4.24%) ▼|TMO500.05-6.37 (-1.26%) ▼|TMUS168.85-5.12 (-2.94%) ▼|TSLA416.37+4.53 (+1.10%) ▲|TXN294.38+8.90 (+3.12%) ▲|UBER73.38-2.12 (-2.81%) ▼|UNH416.48-3.34 (-0.80%) ▼|UNP271.91-0.80 (-0.29%) ▼|UPS106.37-1.64 (-1.52%) ▼|USB60.54-0.22 (-0.36%) ▼|V342.68+1.03 (+0.30%) ▲|VZ42.78-1.32 (-2.99%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.63-0.98 (-0.85%) ▼|XOM136.10+0.04 (+0.03%) ▲|AAPL289.16+7.42 (+2.63%) ▲|ABBV252.55-1.76 (-0.69%) ▼|ABT91.62-1.09 (-1.18%) ▼|ACN123.89-0.85 (-0.68%) ▼|ADBE202.40-4.04 (-1.95%) ▼|AMAT730.21+35.57 (+5.12%) ▲|AMD572.95+33.46 (+6.20%) ▲|AMGN359.32-1.23 (-0.34%) ▼|AMT164.00-4.67 (-2.77%) ▼|AMZN239.47-0.67 (-0.28%) ▼|AVGO375.32+2.87 (+0.77%) ▲|AXP337.93-2.95 (-0.87%) ▼|BA216.73+2.04 (+0.95%) ▲|BAC57.02-0.87 (-1.49%) ▼|BKNG179.97-2.44 (-1.34%) ▼|BLK961.93+11.76 (+1.24%) ▲|BMY57.76-0.81 (-1.37%) ▼|BNY144.96+1.16 (+0.81%) ▲|BRK-B496.56+0.56 (+0.11%) ▲|C140.00-2.49 (-1.75%) ▼|CAT1,063.07+29.88 (+2.89%) ▲|CL91.95-0.46 (-0.49%) ▼|CMCSA24.54+0.32 (+1.30%) ▲|COF200.47-1.81 (-0.89%) ▼|COP104.36+0.16 (+0.15%) ▲|COST936.72-9.96 (-1.05%) ▼|CRM154.85-3.08 (-1.95%) ▼|CSCO118.13+0.43 (+0.36%) ▲|CVS103.39-0.20 (-0.19%) ▼|CVX167.77-0.70 (-0.42%) ▼|DE627.71+2.70 (+0.43%) ▲|DHR190.17-2.61 (-1.35%) ▼|DIS96.82-1.07 (-1.09%) ▼|DUK127.75-0.58 (-0.45%) ▼|EMR143.17+0.35 (+0.25%) ▲|FDX310.30-15.10 (-4.64%) ▼|GD352.36+4.29 (+1.23%) ▲|GE372.14-1.57 (-0.42%) ▼|GEV1,136.11+33.60 (+3.05%) ▲|GILD125.94-0.40 (-0.31%) ▼|GM76.24-1.10 (-1.42%) ▼|GOOG353.23+1.95 (+0.56%) ▲|GOOGL356.25+2.60 (+0.74%) ▲|GS1,012.12-8.09 (-0.79%) ▼|HD351.68+0.87 (+0.25%) ▲|HON223.56-4.24 (-1.86%) ▼|IBM277.94-0.06 (-0.02%) ▼|INTC139.67+7.95 (+6.04%) ▲|INTU261.85-4.55 (-1.71%) ▼|ISRG402.03-3.94 (-0.97%) ▼|JNJ255.29-3.23 (-1.25%) ▼|JPM327.51-1.88 (-0.57%) ▼|KO82.02-0.63 (-0.76%) ▼|LIN519.52+8.46 (+1.65%) ▲|LLY1,209.02-20.91 (-1.70%) ▼|LMT505.63+3.56 (+0.71%) ▲|LOW219.21-0.44 (-0.20%) ▼|LRCX426.47+15.56 (+3.79%) ▲|MA511.55+1.91 (+0.37%) ▲|MCD269.20+2.02 (+0.76%) ▲|MDLZ58.98-1.17 (-1.95%) ▼|MDT79.32-1.62 (-2.00%) ▼|META556.23-6.37 (-1.13%) ▼|MMM162.36-0.08 (-0.05%) ▼|MO72.57-1.48 (-2.00%) ▼|MRK128.35-1.03 (-0.80%) ▼|MS209.12-2.60 (-1.23%) ▼|MSFT370.29+1.72 (+0.47%) ▲|MU1,143.41-1.88 (-0.16%) ▼|NEE88.15-0.51 (-0.58%) ▼|NFLX72.68-1.11 (-1.50%) ▼|NKE41.04-0.45 (-1.07%) ▼|NOW97.61-2.37 (-2.37%) ▼|NVDA198.38+3.41 (+1.75%) ▲|ORCL145.41-2.36 (-1.59%) ▼|PEP136.34-2.34 (-1.69%) ▼|PFE24.08-0.29 (-1.19%) ▼|PG145.79-2.67 (-1.80%) ▼|PLTR116.87+1.17 (+1.01%) ▲|PM179.75-3.13 (-1.71%) ▼|QCOM186.61-2.11 (-1.12%) ▼|RTX188.55+1.22 (+0.65%) ▲|SBUX102.88-1.18 (-1.13%) ▼|SCHW92.47+1.92 (+2.12%) ▲|SO96.40-0.36 (-0.37%) ▼|SPG224.92-2.65 (-1.16%) ▼|T20.90-0.93 (-4.24%) ▼|TMO500.05-6.37 (-1.26%) ▼|TMUS168.85-5.12 (-2.94%) ▼|TSLA416.37+4.53 (+1.10%) ▲|TXN294.38+8.90 (+3.12%) ▲|UBER73.38-2.12 (-2.81%) ▼|UNH416.48-3.34 (-0.80%) ▼|UNP271.91-0.80 (-0.29%) ▼|UPS106.37-1.64 (-1.52%) ▼|USB60.54-0.22 (-0.36%) ▼|V342.68+1.03 (+0.30%) ▲|VZ42.78-1.32 (-2.99%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.63-0.98 (-0.85%) ▼|XOM136.10+0.04 (+0.03%) ▲|
28.8 C
New York
Tuesday, June 30, 2026

Tag: study

newssourceFORcompanyinformationcontent1releasesmarket

DARYL WARD, PH.D., NAMED INTERIM EXECUTIVE DIRECTOR OF THE ASHLEY GIBSON BARNETT MUSEUM OF ART

LAKELAND, Fla., June 13, 2025 /PRNewswire/ -- The Ashley Gibson Barnett Museum of Art (The AGB) at Florida Southern College is pleased to announce the...

CureLab Veterinary’s ElenaVet™ Gene Therapy Delivers 90% Success in Pet-Dog Osteoarthritis Study

Frontiers in Veterinary Science paper reports rapid, significant pain relief with weekly p62-plasmid injections and no significant side-effects BOSTON, June 13, 2025 /PRNewswire/ -- CureLab...

UBC researchers awarded more than $6.5 million from Brain Canada to advance neuroscience research

VANCOUVER, BC, June 13, 2025 /CNW/ - UBC Faculty of Medicine researchers have been awarded more than $6.5 million from Brain Canada's Platform Support...

Trusted Crypto Casinos Are Taking Over Online Gambling in 2025: Exclusive Report By Radcred

Radcred’s exclusive 2025 study reveals the safest, fastest-paying crypto casinos reshaping online gambling. See trends, data, and tips. 
Radcred’s exclusive 2025 study reveals the safest, fastest-paying crypto casinos reshaping online gambling. See trends, data, and tips.

WRJ Design Wins National Attention for Jackson Hole Home as “Ode to Art and Beauty”

LUXE honors design team with cover story featuring project inspired by the majestic Teton landscape, iconic modern architecture and a stunning blue-chip art collection JACKSON...

Anytime Fitness Asia Launches Its Biggest-Ever Regional Brand Campaign – “Train For Your Life”

HONG KONG, June 13, 2025 /PRNewswire/ -- Anytime Fitness, Asia's largest 24-hour fitness network, launches its most impactful brand campaign to date: "Train For Your...

Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma –

Nota AI Achieves 100% Accuracy Through Sony IMX500®-Powered Smart Traffic Solution, Demonstrating Global Competitiveness

On-device AI optimization delivers high-performance AI on Sony's IMX500 chipset with minimal power consumption and cost100% accuracy achieved in AI Voucher project, recognized as a...

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

CLEVELAND, June 13, 2025 /PRNewswire/ -- Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in the TRANSFORM II randomized...

Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025

New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinib 
New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinib

Airis NEO P40000: Redefining Disposable Vapes, Delivering a Premium Experience of Pure and Smooth Vaping

SHENZHEN, China, June 13, 2025 (GLOBE NEWSWIRE) -- As a leading brand in the global vaping industry, Airis once again redefines industry expectations with the launch of its latest flagship product, the NEO P40000. This revolutionary product integrates an intelligent monitoring system, triple-core ultra-fast vaporization, five-level nicotine adjustment, and 15 authentic flavors, it not only redefines the user experience of disposable e-cigarettes but also leads global users into a new era of “smart, premium, and long-lasting” vaping.

Analyzing Gender Disparity in Retirement Savings—Strategic Insights for Financial Planning

**Retirement Planning: A Structured Approach for Long-Term Financial Security** All working Americans require robust retirement savings strategies, with a heightened focus necessary for women due...

BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review

STOCKHOLM, June 13, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase...

Successful ammonia transfers in the Pilbara yield key safety and operational insights for future ammonia bunkering operations

Comprehensive safety studies confirm that ship-to-ship ammonia transfer at anchorage can be both safe and practicableThorough planning, infrastructure readiness, vessel compatibility and clear communications...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStudy

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers